Progesterone Receptor Positive (PR+) Breast Cancer: Characteristics, Treatment and Prognosis
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
ER+ and PR+ Breast Cancer: Key Statistics and Molecular Insights
ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...
Hosted on MSN13d
What To Know About HR+/HER2- Breast Cancer
HR+/HER2- breast cancer involves tumor cells that test positive for hormone receptors and negative for HER2 proteins. Cancer ...
Medscape4d
Third-Generation Oral Contraceptives: Future Implications of Current Use
MR = Mineralocorticoid receptor; PR = Progesterone receptor. The relative binding affinity (%) of the main progestins discussed in this paper for the different steroid receptors is indicated.
Medical News Today14d
What to know about triple-positive breast cancer
Triple-positive breast cancer is a type of breast cancer that tests positive for estrogen receptors, progesterone receptors, and high levels of HER2 protein. Some types of breast cancer cells use ...
Yahoo Finance9d
FDA Files Corcept’s New Drug Application for Relacorilant as Treatment for Patients With Hypercortisolism
hypokalemia or QT prolongation – serious adverse events that can arise in patients taking currently approved medications – ...
The Daily News14d
New vaccine could help fight breast cancer
For many women, finding out that they have breast cancer is the worst news they can receive. Even worse news is if the breast cancer is termed “triple-negative,” which is ...
FDA files Corcept’s NDA for Relacorilant as treatment in Hypercortisolism
Corcept Therapeutics (CORT) announced that the FDA filed its New Drug Application (NDA) submission for its proprietary, selective cortisol ...